Role of μ-opioid receptors in formalin-induced pain behavior in mice

Experimental Neurology

Volumn 184, Issue 2, 2003, Pages 839-845

  Zhao, Cheng Shui ^a   Tao, Yuan Xiang ^a   Tall, Jill M ^a   Donovan, David M ^b   Meyer, Richard A ^a   Raja, Srinivasa N ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

c fos; Formalin test; Knockout; Naloxone; Opioid receptors

Indexed keywords

FORMALDEHYDE; MU OPIATE RECEPTOR; NALOXONE; NARCOTIC ANTAGONIST; PROTEIN C FOS;

ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; GENE EXPRESSION; HOMOZYGOSITY; INJECTION; KNOCKOUT GENE; LUMBAR SPINAL CORD; MALE; MOLECULAR MECHANICS; MOUSE; NOCICEPTION; NONHUMAN; ONCOGENE C FOS; PAIN; PRIORITY JOURNAL; PROTEIN FUNCTION; WILD TYPE; ANIMAL; ANIMAL BEHAVIOR; BIOSYNTHESIS; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; IMMUNOHISTOCHEMISTRY; METABOLISM; MOUSE MUTANT; PAIN ASSESSMENT; PATHOPHYSIOLOGY; PHYSIOLOGY; SPINAL CORD;

ANIMALS; BEHAVIOR, ANIMAL; FORMALDEHYDE; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, KNOCKOUT; NALOXONE; NARCOTIC ANTAGONISTS; PAIN; PAIN MEASUREMENT; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTORS, OPIOID, MU; SPINAL CORD;

EID: 1642526521     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4886(03)00346-7     Document Type: Article

References (42)

1. Abbott F.V., Ocvirk R., Najafee R., Franklin K.B. Improving the efficiency of the formalin test. Pain. 83:1999;561-569.
2. Bullitt E. Somatotopy of spinal nociceptive processing. J. Comp. Neurol. 312:1991;279-290.
3. Dickenson A.H., Sullivan A.F. Peripheral origins and central modulation of subcutaneous formalin-induced activity of rat dorsal horn neurones. Neurosci. Lett. 83:1987;207-211.
4. Dickenson A.H., Chapman V., Green G.M. The pharmacology of excitatory and inhibitory amino acid-mediated events in the transmission and modulation of pain in the spinal cord. Gen. Pharmacol. 28:1997;633-638.
5. Dubner R., Ren K. Endogenous mechanisms of sensory modulation. Pain. (Suppl. 6):1999;S45-S53.
6. Dubuisson D., Dennis S.G. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain. 4:1977;161-174.
7. Gogas K.R., Presley R.W., Levine J.D., Basbaum A.I. The antinociceptive action of supraspinal opioids results from an increase in descending inhibitory control: correlation of nociceptive behavior and c-fos expression. Neuroscience. 42:1991;617-628.
8. Guhring H., Schuster J., Hamza M., Ates M., Kotalla C.E., Brune K. HU-210 shows higher efficacy and potency than morphine after intrathecal administration in the mouse formalin test. Eur. J. Pharmacol. 429:2001;127-134.
9. Hamalainen M.M., Alila A., Johansson G., Pertovaara A. Cocaine-induced effects on pain behavior and C-fos expression in the spinal dorsal horn of the rat. Neurosci. Res. Commun. 19:1996;67-74.
10. Hamba M. Effects of lesion and stimulation of rat hypothalamic arcuate nucleus on the pain system. Brain Res. Bull. 21:1988;757-763.
11. Hammond D.L., Presley R., Gogas K.R., Basbaum A.I. Morphine or U-50,488 suppresses Fos protein-like immunoreactivity in the spinal cord and nucleus tractus solitarii evoked by a noxious visceral stimulus in the rat. J. Comp. Neurol. 315:1992;244-253.
12. Harris J.A. Using c-fos as a neural marker of pain. Brain Res. Bull. 45:1998;1-8.
13. Hunskaar S., Hole K. The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain. 30:1987;103-114.
14. Hunt S.P., Pini A., Evan G. Induction of c-fos-like protein in spinal cord neurons following sensory stimulation. Nature. 328:1987;632-634.
15. Kocher L. Systemic naloxone does not affect pain-related behaviour in the formalin test in rat. Physiol. Behav. 43:1988;265-268.
16. Machelska H., Labuz D., Przewlocki R., Przewlocka B. Inhibition of nitric oxide synthase enhances antinociception mediated by mu, delta and kappa opioid receptors in acute and prolonged pain in the rat spinal cord. J. Pharmacol. Exp. Ther. 282:1997;977-984.
17. Martin M., Matifas A., Maldonado R., Kieffer B.L. Acute antinociceptive responses in single and combinatorial opioid receptor knockout mice: distinct mu, delta and kappa tones. Eur. J. Neurosci. 17:2003;701-708.
18. Monroe P.J., Hawranko A.A., Smith D.L., Smith D.J. Biochemical and pharmacological characterization of multiple beta-endorphinergic antinociceptive systems in the rat periaqueductal gray. J. Pharmacol. Exp. Ther. 276:1996;65-73.
19. Munglani R., Hunt S.P. Proto-oncogenes: basic concepts and stimulation induced changes in the spinal cord. Prog. Brain Res. 104:1995;283-298.
20. Murray C.W., Porreca F., Cowan A. Methodological refinements to the mouse paw formalin test. An animal model of tonic pain. J. Pharmacol. Methods. 20:1988;175-186.
21. Narita M., Tseng L.F. Evidence for the existence of the beta-endorphin-sensitive "epsilon-opioid receptor" in the brain: the mechanisms of epsilon-mediated antinociception. Jpn. J. Pharmacol. 76:1998;233-253.
22. Ossipov M.H., Kovelowski C.J., Wheeler-Aceto H., Cowan A., Hunter J.C., Lai J., Malan T.P. Jr., Porreca F. Opioid antagonists and antisera to endogenous opioids increase the nociceptive response to formalin: demonstration of an opioid kappa and delta inhibitory tone. J. Pharmacol. Exp. Ther. 277:1996;784-788.
23. Pasternak G.W. Pharmacological mechanisms of opioid analgesics. Clin. Neuropharmacol. 16:1993;1-18.
24. Porro C.A., Tassinari G., Facchinetti F., Panerai A.E., Carli G. Central beta-endorphin system involvement in the reaction to acute tonic pain. Exp. Brain Res. 83:1991;549-554.
25. Presley R.W., Menetrey D., Levine J.D., Basbaum A.I. Systemic morphine suppresses noxious stimulus-evoked Fos protein-like immunoreactivity in the rat spinal cord. J. Neurosci. 10:1990;323-335.
26. Przewlocka B., Mika J., Labuz D., Toth G., Przewlocki R. Spinal analgesic action of endomorphins in acute, inflammatory and neuropathic pain in rats. Eur. J. Pharmacol. 367:1999;189-196.
27. Puig S., Sorkin L.S. Formalin-evoked activity in identified primary afferent fibers: systemic lidocaine suppresses phase-2 activity. Pain. 64:1996;345-355.
28. Shannon H.E., Lutz E.A. Comparison of the peripheral and central effects of the opioid agonists loperamide and morphine in the formalin test in rats. Neuropharmacology. 42:2002;253-261.
29. Shook J.E., Kazmierski W., Wire W.S., Lemcke P.K., Hruby V.J., Burks T.F. Opioid receptor selectivity of beta-endorphin in vitro and in vivo: mu, delta and epsilon receptors. J. Pharmacol. Exp. Ther. 246:1988;1018-1025.
30. Soignier R.D., Vaccarino A.L., Brennan A.M., Kastin A.J., Zadina J.E. Analgesic effects of endomorphin-1 and endomorphin-2 in the formalin test in mice. Life Sci. 67:2000;907-912.
31. Sora I., Takahashi N., Funada M., Ujike H., Revay R.S., Donovan D.M., Miner L.L., Uhl G.R. Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc. Natl. Acad. Sci. U. S. A. 94:1997;1544-1549.
32. Sugimoto M., Kuraishi Y., Satoh M., Takagi H. Involvement of medullary opioid-peptidergic and spinal noradrenergic systems in the regulation of formalin-induced persistent pain. Neuropharmacology. 25:1986;481-485.
33. Taylor B.K., Peterson M.A., Basbaum A.I. Continuous intravenous infusion of naloxone does not change behavioral, cardiovascular, or inflammatory responses to subcutaneous formalin in the rat. Pain. 69:1997;171-177.
34. Tjolsen A., Berge O.G., Hunskaar S., Rosland J.H., Hole K. The formalin test: an evaluation of the method. Pain. 51:1992;5-17.
35. Uhl G.R., Sora I., Wang Z. The mu opiate receptor as a candidate gene for pain: polymorphisms, variations in expression, nociception, and opiate responses. Proc. Natl. Acad. Sci. U. S. A. 96:1999;7752-7755.
36. Vaccarino A.L., Tasker R.A., Melzack R. Systemic administration of naloxone produces analgesia in BALB/c mice in the formalin pain test. Neurosci. Lett. 84:1988;103-107.
37. Wettstein J.G., Grouhel A. Opioid antagonist profile of SC nor-binaltorphimine in the formalin paw assay. Pharmacol. Biochem. Behav. 53:1996;411-416.
38. Wheeler-Aceto H., Cowan A. Naloxone causes apparent antinociception and pronociception simultaneously in the rat paw formalin test. Eur. J. Pharmacol. 236:1993;193-199.
39. Wu H., Hung K., Ohsawa M., Mizoguchi H., Tseng L.F. Antisera against endogenous opioids increase the nocifensive response to formalin: demonstration of inhibitory beta-endorphinergic control. Eur. J. Pharmacol. 421:2001;39-43.
40. Wu H.E., Hung K.C., Mizoguchi H., Nagase H., Tseng L.F. Roles of endogenous opioid peptides in modulation of nocifensive response to formalin. J. Pharmacol. Exp. Ther. 300:2002;647-654.
41. Zadina J.E., Martin-Schild S., Gerall A.A., Kastin A.J., Hackler L., Ge L.J., Zhang X. Endomorphins: novel endogenous mu-opiate receptor agonists in regions of high mu-opiate receptor density. Ann. N. Y. Acad. Sci. 897:1999;136-144.
42. Zangen A., Herzberg U., Vogel Z., Yadid G. Nociceptive stimulus induces release of endogenous beta-endorphin in the rat brain. Neuroscience. 85:1998;659-662.